NO912872D0 - Fremgangsmaate og middel for fremstilling av et stabilt farmasoeytisk preparat. - Google Patents

Fremgangsmaate og middel for fremstilling av et stabilt farmasoeytisk preparat.

Info

Publication number
NO912872D0
NO912872D0 NO912872A NO912872A NO912872D0 NO 912872 D0 NO912872 D0 NO 912872D0 NO 912872 A NO912872 A NO 912872A NO 912872 A NO912872 A NO 912872A NO 912872 D0 NO912872 D0 NO 912872D0
Authority
NO
Norway
Prior art keywords
preparing
pharmaceutical preparation
stable pharmaceutical
stable
preparation
Prior art date
Application number
NO912872A
Other languages
English (en)
Norwegian (no)
Inventor
Bruce Allan Ross
Richard Victor Vivilecchia
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO912872D0 publication Critical patent/NO912872D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO912872A 1990-07-25 1991-07-23 Fremgangsmaate og middel for fremstilling av et stabilt farmasoeytisk preparat. NO912872D0 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55723490A 1990-07-25 1990-07-25

Publications (1)

Publication Number Publication Date
NO912872D0 true NO912872D0 (no) 1991-07-23

Family

ID=24224569

Family Applications (1)

Application Number Title Priority Date Filing Date
NO912872A NO912872D0 (no) 1990-07-25 1991-07-23 Fremgangsmaate og middel for fremstilling av et stabilt farmasoeytisk preparat.

Country Status (30)

Country Link
EP (1) EP0468929B1 (it)
JP (1) JP2502849B2 (it)
KR (1) KR100227156B1 (it)
AT (1) AT400519B (it)
AU (1) AU639354B2 (it)
CA (1) CA2047802C (it)
CH (1) CH683150A5 (it)
CZ (1) CZ280184B6 (it)
DE (1) DE4124409B4 (it)
DK (1) DK0468929T3 (it)
ES (1) ES2061218T3 (it)
FI (1) FI98127C (it)
GB (1) GB2246296B (it)
HU (1) HU222489B1 (it)
IE (1) IE66184B1 (it)
IL (1) IL98934A (it)
IT (1) IT1290797B1 (it)
LU (1) LU87980A1 (it)
MX (1) MX9100357A (it)
MY (1) MY107183A (it)
NO (1) NO912872D0 (it)
NZ (1) NZ239078A (it)
PL (1) PL167712B1 (it)
PT (1) PT98417B (it)
RU (1) RU2075310C1 (it)
SA (1) SA92130106B1 (it)
SK (1) SK278563B6 (it)
TW (1) TW212757B (it)
UA (1) UA26064A1 (it)
ZA (1) ZA915861B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2942495A (en) * 1994-07-13 1996-02-16 Lek Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Process for the preparation of compounds having ace inhibitory action as well as novel compounds useful as starting materials or intermediates in said process
DE4444051A1 (de) * 1994-12-10 1996-06-13 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
HU222497B1 (hu) * 1996-12-18 2003-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Enalapril-maleátot tartalmazó stabilizált gyógyszerkészítmény és eljárás előállítására
PL344586A1 (en) * 1998-06-05 2001-11-05 Warner Lambert Co Stabilization of compositions containing ace inhibitors using magnesium oxide
KR100483080B1 (ko) * 2001-09-21 2005-04-14 한인규 염산·베타인(betaine·HCl), 판크레아틴, 제2인산 칼슘, 크롬 피콜리네이트, 락토바실러스속·비피도박테리아속·스트렙토코커스속·프럭토 올리고당, 비타민, 미네랄을 유효성분으로 구성된 것을 특징으로 하는 증체개선용 영양강화 사료첨가제
US6462022B1 (en) † 2001-09-24 2002-10-08 Astrazeneca Ab Lisinopril compositions having large-particle DCPD
DE60312857T2 (de) * 2002-01-15 2008-01-17 Actavis Group Hf. Formulierungen von quinapril und verwandte ace-hemmer
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
ES2364011B1 (es) 2009-11-20 2013-01-24 Gp Pharm, S.A. Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
BR112019022142A2 (pt) 2017-05-31 2020-05-12 Boehringer Ingelheim International Gmbh Composição farmacêutica e forma de dosagem farmacêutica compreendendo (e)-4-(2-(aminometil)-3-fluoroalilóxi)-n-terc-butilbenzamida, processo para sua preparação, métodos para tratamento e seus usos

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB895027A (en) * 1959-08-03 1962-04-26 Bristol Myers Co Therapeutic tetracycline compositions
GB1437788A (en) * 1973-01-31 1976-06-03 Gist Brocades Nv Therapeutic compositions
HU173823B (hu) * 1975-07-25 1979-08-28 Chinoin Gyogyszer Es Vegyeszet Sposob poluchenija stabil'nogo lechebnogo preparata dlja oral'noj dozirovki, kotoryj soderzhit proizvodnyj gomopirimidazola
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4575539A (en) * 1985-06-03 1986-03-11 E. R. Squibb & Sons, Inc. Drug delivery systems including novel interpenetrating polymer networks and method
US4900559A (en) * 1985-12-12 1990-02-13 Briston-Myers Company Stabilized enteric coated aspirin granules and process of preparation
DE3627613A1 (de) * 1986-08-14 1988-02-18 Merck Patent Gmbh Pharmazeutische zubereitung
US4793998A (en) * 1986-10-20 1988-12-27 Warner-Lambert Company Stabilized drug compositions
US4830853A (en) * 1986-10-20 1989-05-16 Warner-Lambert Company Drug compositions stabilized against oxidation
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
AU608891B2 (en) * 1987-09-24 1991-04-18 Merck & Co., Inc. Solubility modulated drug delivery device
US4912096A (en) * 1989-06-26 1990-03-27 E. R. Squibb & Sons, Inc. Method for preventing or treating depression employing an ace inhibitor

Also Published As

Publication number Publication date
GB9115893D0 (en) 1991-09-04
FI913554A0 (fi) 1991-07-24
IL98934A (en) 1996-07-23
CZ280184B6 (cs) 1995-11-15
UA26064A1 (uk) 1999-04-30
ATA147691A (de) 1995-06-15
CH683150A5 (de) 1994-01-31
MY107183A (en) 1995-09-30
IT1290797B1 (it) 1998-12-11
SA92130106B1 (ar) 2005-10-16
EP0468929A2 (en) 1992-01-29
TW212757B (it) 1993-09-11
AT400519B (de) 1996-01-25
FI98127B (fi) 1997-01-15
PL291219A1 (en) 1992-08-24
JPH04253923A (ja) 1992-09-09
PL167712B1 (en) 1995-10-31
AU8128691A (en) 1992-01-30
HU222489B1 (hu) 2003-07-28
PT98417B (pt) 1999-01-29
DE4124409A1 (de) 1992-01-30
MX9100357A (es) 1992-02-28
JP2502849B2 (ja) 1996-05-29
LU87980A1 (fr) 1993-02-15
IE66184B1 (en) 1995-12-13
RU2075310C1 (ru) 1997-03-20
IE912608A1 (en) 1992-01-29
FI913554A (fi) 1992-01-26
KR100227156B1 (ko) 1999-10-15
ITRM910554A1 (it) 1993-01-23
EP0468929A3 (en) 1992-02-19
ES2061218T3 (es) 1994-12-01
FI98127C (fi) 1997-04-25
GB2246296A (en) 1992-01-29
GB2246296B (en) 1994-04-06
SK278563B6 (en) 1997-10-08
ZA915861B (en) 1993-03-31
DK0468929T3 (da) 1994-12-27
ITRM910554A0 (it) 1991-07-23
CA2047802C (en) 2003-05-06
DE4124409B4 (de) 2004-11-18
NZ239078A (en) 1993-10-26
IL98934A0 (en) 1992-07-15
HU9102385D0 (en) 1991-12-30
HUT59819A (en) 1992-07-28
CA2047802A1 (en) 1992-01-26
AU639354B2 (en) 1993-07-22
PT98417A (pt) 1992-06-30
KR920002146A (ko) 1992-02-28
EP0468929B1 (en) 1994-09-28
CS230991A3 (en) 1992-04-15

Similar Documents

Publication Publication Date Title
NO911020D0 (no) Fremgangsmaate og preparat for koiontoforese.
IS3720A7 (is) Afleiður dialkoxy-pyridinyl-benzimidazole, aðferðvið lögun þeirra og lyfjafræðileg notkun
NO885641D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk preparat.
NO903264D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av mikropartikler.
NO882103L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
FI903382A0 (fi) Topiskt anbringbara farmaceutiska preparat.
NO893896L (no) Farmasoeytiske formuleringer og fremgangsmaate for fremstilling av disse.
NO913668D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for nasal tilfoersel.
NO891866L (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO179853C (no) Fremgangsmåte for fremstilling av et smaksgivende middel
NO179434C (no) Fremgangsmåte for fremstilling av et farmasöytisk preparat, og anvendelse av en vannopplöselig monoester som et solubiliserende middel
DK192589A (da) Pyridoncarboxylsyrederivat, fremgangsmaade til fremstilling deraf og middel indeholdende et pyridoncarboxylsyrederivat
NO961000D0 (no) Piperidinderivater, fremgangsmåte for fremstilling derav og medikament og preparat inneholdende slike
NO912872D0 (no) Fremgangsmaate og middel for fremstilling av et stabilt farmasoeytisk preparat.
NO901232D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO892494D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
NO894103D0 (no) Kromanderivater og fremgangsmaate for fremstilling derav.
FI882965A0 (fi) Aminocyklopentyletrar och deras framstaellning och farmaceutiska preparat.
NO913162D0 (no) Farmasoeytisk preparat for behandling av tonsillitt.
FI101600B1 (fi) Menetelmä farmaseuttisen formulaation valmistamiseksi
NO900252D0 (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
FI883747A (fi) Topiskt anvaendbara farmaceutiska preparat.
NO893963L (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.
NO903442L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat med regulert biologisk tilgjengelighet.
NO911298D0 (no) Farmasoeytisk preparat og anvendelse derav.